BioSpace News Archive

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that on July 31, 2020 , the Company received a letter from the Listing Qualifications Department of The NASDAQ Stock Market indicating that it has regained compliance with the $1.00 minimum bid price requirement for continued listing on The NASDAQ Capital Mark

Bioclinica, a leading provider of clinical science and technology expertise supporting the life science industry in bringing new therapies to market, announced today that Joyce Suhy, Ph.D., Senior Vice President of Medical Imaging, is recognized by PharmaVOICE as one of the 100 most inspiring people in the life-sciences industry.

JEOL Ltd. announces the release of a new scanning electron microscope, the JSM-IT700HR for unprecedentedly high throughput in August 2020.

ntra-articular hyaluronic acid (IHA) knee osteoarthritis (OA) pain relief treatments had lower total medical care costs vs. patients treated with intra-articular corticosteroids (ICS) or total knee arthroplasty (TKA).

20/20 GeneSystems, Inc. is proud to announce that in partnership with Linkou Chang Gung Memorial Hospital, the largest hospital in Taiwan, it has won the 2020 Taipei Biotech “Technology Transfer Cooperation Award” Gold Medal Award,

FDA Commissioner Dr. Stephen Hahn says, “These types of tests will be a game changer” LOS ANGELES, CA / ACCESSWIRE / August 3, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co , through its subsidiary Pharma Tech Solutions, Inc., today announced its support for the recently issued FDA Covid-19 At-Home Use Template saying it, “Contains much of what was in our May 1 st At-Home Application to the FDA.” The company says it is 100 percent behind

Today, Arthur Kapoor, president and CEO of HealthEC, and Jay Rosen, founder and president of Health Management Associates (HMA), announced the two firms have engaged in an effort designed to accelerate improvements in healthcare service delivery and outcomes.

The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a new fund to provide copayment and premium assistance to Medicare patients living with B-Cell Lymphoma (BCL).

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the publication of a manuscript in Nature Cancer1 that validates the ability of its Signatera™ personalized circulating tumor DNA (ctDNA) technology to evaluate tumor response to immunotherapy in 25 different types of solid cancer.

Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson disease, today announced that Dr. Jeanne Loring, co-founder and Chief Scientific Officer, will transition to the role of Special Advisor to the Company’s Research and Development Committee.